Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Luzindole (N-0774) is a selective melatonin receptor antagonist. Luzindole inhibits experimental autoimmune encephalomyelitis and exerts antidepressant-like activity. Luzindole preferentially targets MT2 (Mel1b) over MT1 (Mel1a) with Ki values of 10.2 and 158 nM for human MT2 and MT1, respectively.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 47.00 | |
5 mg | In stock | $ 147.00 | |
10 mg | In stock | $ 249.00 | |
25 mg | In stock | $ 419.00 | |
50 mg | In stock | $ 618.00 | |
100 mg | In stock | $ 875.00 | |
500 mg | In stock | $ 1,750.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 158.00 |
Description | Luzindole (N-0774) is a selective melatonin receptor antagonist. Luzindole inhibits experimental autoimmune encephalomyelitis and exerts antidepressant-like activity. Luzindole preferentially targets MT2 (Mel1b) over MT1 (Mel1a) with Ki values of 10.2 and 158 nM for human MT2 and MT1, respectively. |
Targets&IC50 | MT2 receptor:10.2 nM(ki), MT1 receptor:158 nM(ki) |
In vitro | Luzindole (5-10 μg/ml) suppresses antigen-specific proliferation of the MBP-reactive LV-4 T cell line[1]. |
In vivo | Luzindole (30 mg/kg i.p.) decreases the time of immobility in a dose-dependent manner, the effect being more pronounced at midnight (60% reduction) than at noon (39% reduction). Luzindole (30 mg/kg; i.p.; days 0-5) inhibits experimental autoimmune encephalomyelitis[2]. Luzindole (30 mg/kg i.p.) did not modify the time of immobility either at noon or midnight in the albino ND/4 mouse, or in the C57BL/6J mouse, which does not produce melatonin[3]. The effect of luzindole is time-dependent, showing a maximal effect at 60 min. The anti-immobility effect of luzindole (10 mg/kg i.p.) is prevented by the administration of melatonin (30 mg/kg i.p.). |
Synonyms | N-0774 |
Molecular Weight | 292.37 |
Formula | C19H20N2O |
CAS No. | 117946-91-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 100 mg/mL (342.03 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Luzindole 117946-91-5 GPCR/G Protein Neuroscience Melatonin Receptor MT Receptor N0774 inhibit autoimmune anti-immobility subtype preferentially selective N 0774 Inhibitor encephalomyelitis antidepressant-like N-0774 inhibitor